Should You Buy Creative Medical Technology Holdings Inc (CELZ) Stock After it Is Up 10.93% in a Week?

Creative Medical Technology Holdings Inc (CELZ) stock is higher by 10.93% over the past week and gets a Neutral rating from InvestorsObserver Sentiment Indicator.

Creative Medical Technology Holdings Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on CELZ!

See Full CELZ Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With CELZ Stock Today?

Creative Medical Technology Holdings Inc (CELZ) stock is trading at $4.87 as of 3:22 PM on Wednesday, Mar 6, a gain of $0.74, or 17.95% from the previous closing price of $4.13. Volume today is high. So far 3,446,858 shares have traded compared to average volume of 5,573 shares. The stock has traded between $4.39 and $5.88 so far today.

More About Creative Medical Technology Holdings Inc

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues. Click Here to get the full Stock Report for Creative Medical Technology Holdings Inc stock.